Repositorio Dspace

Recommendations for follow-up of colorectal cancer survivors

Mostrar el registro sencillo del ítem

dc.contributor.author Vera, R
dc.contributor.author Aparicio, J
dc.contributor.author Carballo-Álvarez, Luis-Fernando
dc.contributor.author Esteva, M
dc.contributor.author González-Flores, E
dc.contributor.author Santianes, J
dc.contributor.author Santolaya, F
dc.contributor.author Fernández-Cebrián, J-M
dc.date.accessioned 2026-02-12T12:19:51Z
dc.date.available 2026-02-12T12:19:51Z
dc.date.issued 2019-10
dc.identifier.citation Vera R, Aparicio J, Carballo F, Esteva M, González-Flores E, Santianes J, et al. Recommendations for follow-up of colorectal cancer survivors. Clin Transl Oncol. octubre de 2019;21(10):1302-11.
dc.identifier.issn 1699-048X
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/24459
dc.description.abstract Colorectal cancer (CRC) is one of the tumours with the highest incidence and mortality in the Spanish population. Nevertheless, the advances in prevention and treatment have contributed to an increased number of patients who survive for prolonged periods of time. In addition, despite recurrences, improved survival following metastasis resection is likewise on the rise. This underscores the importance of carrying out follow-up programmes even in low-risk patients for the early detection of recurrence. The main objective of this article is to provide a set of recommendations for optimising the follow-up of CRC survivors as well as for managing the sequelae that result from either pharmacological or surgical treatment.
dc.language.iso eng
dc.publisher SPRINGER INTERNATIONAL PUBLISHING AG
dc.rights Attribution 4.0 International
dc.rights.uri http://creativecommons.org/licenses/by/4.0 *
dc.subject.mesh Antineoplastic Agents/adverse effects
dc.subject.mesh Cancer Survivors
dc.subject.mesh Carcinoembryonic Antigen/analysis
dc.subject.mesh Colonic Neoplasms/diagnosis/pathology/therapy
dc.subject.mesh Colonoscopy
dc.subject.mesh Continuity of Patient Care
dc.subject.mesh Female
dc.subject.mesh Humans
dc.subject.mesh Liver Neoplasms/diagnostic imaging/secondary
dc.subject.mesh Lung Neoplasms/diagnostic imaging/secondary
dc.subject.mesh Male
dc.subject.mesh Neoplasm Recurrence, Local/diagnosis/prevention & control
dc.subject.mesh Neoplasm Staging
dc.subject.mesh Oxaliplatin/adverse effects
dc.subject.mesh Patient Care Team
dc.subject.mesh Population Surveillance
dc.subject.mesh Postoperative Complications
dc.subject.mesh Primary Prevention
dc.subject.mesh Radiotherapy/adverse effects
dc.subject.mesh Rectal Neoplasms/diagnosis/pathology/therapy
dc.subject.mesh Secondary Prevention
dc.subject.mesh Sexual Dysfunction, Physiological/etiology
dc.subject.mesh Time Factors
dc.title Recommendations for follow-up of colorectal cancer survivors
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 30762206
dc.relation.publisherversion http://link.springer.com/10.1007/s12094-019-02059-1
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1007/s12094-019-02059-1
dc.journal.title Clinical & Translational Oncology
dc.identifier.essn 1699-3055


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution 4.0 International Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta